Current Neuro-Oncology

Volume 7 Number 6
30 June 2005

Home > Publications > Current Neuro-Oncology > Volume 7, Year 2005 > Number 6, 30 June

Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J.
Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
Strahlenther Onkol. 2005 Jun;181(6):372-7. doi: 10.1007/s00066-005-1359-x. PMID: 15925979. Interventional study. ˍ

Demir MK, Hakan T, Akinci O, Berkman Z.
Primary cerebellar glioblastoma multiforme.
Diagn Interv Radiol. 2005 Jun;11(2):83-6. PMID: 15957093. Case report. ˍ


Mourad PD, Farrell L, Stamps LD, Chicoine MR, Silbergeld DL.
Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
Surg Neurol. 2005 Jun 1;63(6):511-9. doi: 10.1016/j.surneu.2004.08.062. PMID: 15936366. Laboratory investigation. ˍ

Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M, Tanaka R.
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
Clin Cancer Res. 2005 Jun 1;11(11):4160-7. doi: 10.1158/1078-0432.CCR-05-0120. PMID: 15930352. Interventional study. ˍ


Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, Tannenbaum C, Barnett G, Finke JH.
Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.
Cancer Res. 2005 Jun 15;65(12):5428-38. doi: 10.1158/0008-5472.CAN-04-4395. PMID: 15958592. Laboratory investigation. ˍ

Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D.
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
J Natl Cancer Inst. 2005 Jun 15;97(12):880-7. doi: 10.1093/jnci/dji161. PMID: 15956649. Interventional study. ˍ